Abstract
Metabolism is one of the primary routes of drug elimination from the body. This process comprises of mechanisms, such as oxidation and conjugation, which lead to inactivation and / or elimination from hepatic, biliary, pulmonary, renal and ocular tissues. Enzymes involved in metabolism are expressed in various tissues of the body, liver being the primary site. Studies involving ocular tissues have demonstrated the expression of several metabolic enzymes such as esterases, peptidases, ketone reductases, and CYP-450s in these tissues. These enzymes play an important role in ocular homeostasis by preventing entry and / or eliminating xenobiotics from the ocular tissues. Scientists have targeted these enzymes in drug design and delivery through prodrug derivatization. The prodrugs undergo biotransformation to the parent drug by ocular enzymatic degradation. This review examines the distribution pattern of various metabolic enzymes in the ocular tissues, their physiological role and utility in targeted prodrug delivery.
Keywords: ocular metabolism, cytochrome p-450, drug delivery, detoxification, prodrugs
Current Drug Metabolism
Title: Role of Metabolism in Ocular Drug Delivery
Volume: 5 Issue: 6
Author(s): Sridhar Duvvuri, Soumyajit Majumdar and Ashim K. Mitra
Affiliation:
Keywords: ocular metabolism, cytochrome p-450, drug delivery, detoxification, prodrugs
Abstract: Metabolism is one of the primary routes of drug elimination from the body. This process comprises of mechanisms, such as oxidation and conjugation, which lead to inactivation and / or elimination from hepatic, biliary, pulmonary, renal and ocular tissues. Enzymes involved in metabolism are expressed in various tissues of the body, liver being the primary site. Studies involving ocular tissues have demonstrated the expression of several metabolic enzymes such as esterases, peptidases, ketone reductases, and CYP-450s in these tissues. These enzymes play an important role in ocular homeostasis by preventing entry and / or eliminating xenobiotics from the ocular tissues. Scientists have targeted these enzymes in drug design and delivery through prodrug derivatization. The prodrugs undergo biotransformation to the parent drug by ocular enzymatic degradation. This review examines the distribution pattern of various metabolic enzymes in the ocular tissues, their physiological role and utility in targeted prodrug delivery.
Export Options
About this article
Cite this article as:
Duvvuri Sridhar, Majumdar Soumyajit and Mitra K. Ashim, Role of Metabolism in Ocular Drug Delivery, Current Drug Metabolism 2004; 5 (6) . https://dx.doi.org/10.2174/1389200043335342
DOI https://dx.doi.org/10.2174/1389200043335342 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Stability-indicating TLC /Densitometric Method for Simultaneous Analysis of Febuxostat and Diclofenac Potassium in Bulk and Tablets
Current Pharmaceutical Analysis The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis
Current Pharmaceutical Biotechnology Altered Glial Plasticity in Animal Models for Mood Disorders
Current Drug Targets Editorial (Thematic Issue: Translational Investigations for Chronic Pain)
Current Pharmaceutical Design Kv1.3 Lymphocyte Potassium Channel Inhibition as a Potential Novel Therapeutic Target in Acute Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Proanthocyanidins in Health Care: Current and New Trends
Current Medicinal Chemistry Occupational Exposure and Respiratory Tract Infections –At Risk Workers in the International Context
Current Respiratory Medicine Reviews Ophthalmological and Otological Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews A Role of Immunotherapy in Metastatic Malignant Melanoma
Central Nervous System Agents in Medicinal Chemistry PARP Inhibitors: An Interesting Pathway also for Non-Small Cell Lung Cancer?
Current Pharmaceutical Design Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review
Current Neuropharmacology Central Nervous System Vasculitis: Still More Questions than Answers
Current Neuropharmacology COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Current Rheumatology Reviews IL-4 and IL-13: Their Pathological Roles in Allergic Diseases and their Potential in Developing New Therapies-Update
Medicinal Chemistry Reviews - Online (Discontinued) Defensins and Other Biocidal Proteins from Bean Seeds with Medicinal Activities
Current Medicinal Chemistry Does in vitro Fertilisation Increase Type 2 Diabetes and Cardiovascular Risk?
Current Diabetes Reviews Double-Stranded RNA Induces MMP-9 Gene Expression in HaCaT Keratinocytes by Tumor Necrosis Factor-α
Inflammation & Allergy - Drug Targets (Discontinued) <i>Helicobacter pylori</i> Reactivates Human Immunodeficiency Virus-1 in Latently Infected Monocytes with Increased Expression of IL-1β and CXCL8
Current Genomics Effective Delivery Routes and Strategies for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)
Current Pharmaceutical Design Xenobiotic Acyl Glucuronides and Acyl CoA Thioesters as Protein- Reactive Metabolites With the Potential to Cause Idiosyncratic Drug Reactions
Current Drug Metabolism